Specialized in nuclear medicine, I worked from 2004 to 2006 at HSR in Milan, then at the hospital of Cuneo (2006/2008) and currently in Turin, at the "City of Health and Science". I deal with mono and bifotonic nuclear medicine in the oncology, neurology and lymphology fields. Pubblications: -“Role of Positron Emission Tomography-Computed Tomography in the management of Anal Cancer”. Int J Radiat Oncol Biol Phys. 2012 Sept 1;84(1):66-72. 1-8F-FDG uptake and calcificationss on positron emission tomography/ computed tomography in octogenarians with severe aortic stenosys”. Minerva Cardioangiol. 2015 Jun; 63(3):187-92. -“PET-CT in Anal Cancer: Indications and Limits”, chapter 9. M. Mistrangelo and A. Lesca. Positron Emission Tomography, book edited by Sandro Misciagna, INTECH. -Dose to specific subregions of pelvic bone marrow defined with FDG-PERT as a predictor of hematologic nadirs during concomitant chemoradiation in anal cancer patients” Med Oncol. 2016 Jul; 33(7):72. -“Sentinel node biopsy for Anal Carcinoma” Clinics in Oncology 2017, vol 2 Article 1311. -“Dose to pelvic bone marrow defined with FDG-PET predicts for hematologic nadirs in anal cancer patients treated with concurrent chemoradiation” Cancer Investigation. -Tailoring the radiotherapy approach in patiens with anal squamous cell carcinoma based on inguinal sentinel lymph node biopsy.- De Nardi et all, J Surg Oncol.2020; 1-7.